Zipp Brandon Joel 4

4 · MALACHITE INNOVATIONS, INC. · Filed Dec 13, 2021

Form 4

Period: 2021-12-10

Chief Science Officer

Transactions

Disposition to Issuer
Stock Option (Right to Buy)
2021-12-10−20,000→ 0 total
Exercise: $2.10From: 2015-05-21Exp: 2025-05-21→ Common Stock (20,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-12-10−2,500→ 0 total
Exercise: $4.20From: 2013-03-11Exp: 2023-03-11→ Common Stock (2,500 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-12-10−15,000→ 0 total
Exercise: $4.20From: 2014-04-03Exp: 2024-04-03→ Common Stock (15,000 underlying)
Award
Stock Option (Right to Buy)
2021-12-10+127,487→ 127,487 total
Exercise: $0.28From: 2021-12-10Exp: 2031-12-10→ Common Stock (127,487 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-12-10−7,500→ 0 total
Exercise: $4.40From: 2013-03-12Exp: 2023-03-12→ Common Stock (7,500 underlying)
Award
Stock Option (Right to Buy)
2021-12-10+22,513→ 150,000 total
Exercise: $0.28From: 2021-12-10Exp: 2031-12-10→ Common Stock (22,513 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-12-10−20,000→ 0 total
Exercise: $3.40From: 2015-01-01Exp: 2025-01-01→ Common Stock (20,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-12-10−75,000→ 0 total
Exercise: $1.81From: 2017-12-27Exp: 2027-12-27→ Common Stock (75,000 underlying)

Footnotes (8)

[F1]An option to purchase 2,500 shares of common stock was granted to the Reporting Person on 3/11/13, 884 shares vested on 3/11/14, and 883 shares vested on each of 3/11/15 and 3/11/16.
[F2]The option provided for vesting in three equal annual installments beginning on 3/12/13.
[F3]The option provided for vesting in eight equal quarterly annual installments beginning on 7/3/14.
[F4]The option provided for vesting in four equal semi-annual installments beginning on 7/1/15.
[F5]The option provided for vesting in four equal semi-annual installments beginning on 11/21/15.
[F6]The option provided for vesting in four equal semi-annual installments beginning on 6/27/18.
[F7]On December 10, 2021, the issuer canceled this option, pursuant to the issuer's option exchange program, the options listed above. In exchange, the Reporting Person received a replacement option to purchase 127,487 shares at an exercise price of $0.277. This replacement option vested immediately.
[F8]On December 10, 2021, the Reporting Person was granted options to purchase 22,513 shares of common stock at an exercise price of $0.277. This option vested immediately.

Documents

1 file